Dr George Kopsidas was recently interviewed by Alan Kohler who highlighted the Company and our approach to cancer therapeutics. Alan Kohler is a well respected Australian financial journalist, newspaper editor and behind the online financial publication, The Constant Investor. Click on the podcast or on title to find the podcast.
Imunexus was invited to present at the 18th Annual Protein Expression Workshop (PEWS). Dr George Kopsidas gave a 40 min talk to a large audience of scientists, protein engineers, representatives from well-respected organisations including CSL, CSIRO, WEHI, the Hudson, the Baker IDI, Melbourne, Monash and La Trobe Universities, and the representatives from the Victorian Government […]
On Sunday the 26th of March the Imunexus team welcomed Channel 10 news to our laboratory in Parkville to discuss the potential impact that Imunexus will have in the area of Breast Cancer. Please follow the link to watch our team in action. Latest technology in the fight against cancer Visiting the team was reporter Georgina […]
It is with sad news that the board wishes to announce the passing of Dr Phil Jennings after battling a long term illness. Phil was a founder of Imunexus and past Chairman who worked alongside Dr George Kopsidas for many years. His eye for detail and ability to provide guidance will be truly missed. Our heartfelt […]
Imunexus has been invited to present at the International Biotechnology Symposium and Exhibition on October 25 at the Melbourne Convention Centre as part of the International Biofest hosted by AusBiotech. George Kopsidas will present in Room 212, Level 2, Melbourne Convention Centre between 3:30-5:00pm Tuesday October 25 as the last presenter on the card. George will […]
Imunexus is busy again in the technology competition space. Following on from our success at Shenzhen we have been shortlisted to present in Melbourne October 4th at the Australian Technology Competition. Hit the icon below to follow the link to the competition information.
On Tuesday September 20th the company moved one step closer to being a public company with a unanimous vote by shareholders in favour of Imunexus converting to a public company. With this change the company can now broaden the investor base and with this comes capital funds to progress the company along its planned development […]
Following on from the recent success at Shenzhen, Graeme Philipson from InnovationAus.com contacted Imunexus and discussed the visit. InnovationAus Interview
Imunexus presented in Shenzhen earlier this year and received 2nd place. What you may not be aware was that George Kopsidas was quite ill and travelled directly from the hospital via ambulance to present. Have a look at the video footage of George’s closing comments to the audience.
The Shenzhen Regional government sponsored a World-wide technology innovation competition Imunexus ranked equal 2nd out of ~1000 global applicants from USA, AUS, NZ, EU, UK, JPN, ISR Imunexus presented to a judging panel of international scientists (including 1 Nobel prize winner in medicine), Biotech and Business Executives and VC’s, Imunexus received $75,000 in prize money Imunexus’ […]